Lixte Biotechnology Holdings, Inc. Stock
Equities
LIXT
US5393193017
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.978 USD | +3.04% | -3.82% | +28.51% |
Apr. 23 | Lixte Biotechnology Files Up to $50 Million Mixed Shelf | MT |
Mar. 27 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 5.29M |
---|---|---|---|---|---|
Net income 2022 | -6M | Net income 2023 | -5M | EV / Sales 2022 | - |
Net cash position 2022 | 5.35M | Net cash position 2023 | 4.2M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.28
x | P/E ratio 2023 |
-0.88
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 68.81% |
1 day | +3.11% | ||
1 week | -3.82% | ||
Current month | +9.42% | ||
1 month | -8.76% | ||
3 months | +44.50% | ||
6 months | -8.48% | ||
Current year | +28.51% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 22-06-16 | |
Director of Finance/CFO | 72 | 20-08-11 | |
Eric Forman
COO | Chief Operating Officer | 44 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
René Bernards
BRD | Director/Board Member | 72 | 22-06-14 |
Chief Executive Officer | 52 | 22-06-16 | |
Yun Yen
BRD | Director/Board Member | 70 | 18-08-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 2.978 | +3.04% | 3 408 |
24-05-03 | 2.89 | +0.27% | 10,200 |
24-05-02 | 2.882 | +0.07% | 8,687 |
24-05-01 | 2.88 | +4.35% | 7,419 |
24-04-30 | 2.76 | -12.10% | 18,682 |
Delayed Quote Nasdaq, May 06, 2024 at 11:01 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+28.51% | 6.5M | |
+21.76% | 47.9B | |
+46.62% | 41.42B | |
-2.18% | 40.7B | |
-6.20% | 28.92B | |
+10.19% | 25.55B | |
-20.87% | 19.27B | |
-0.32% | 12.15B | |
+31.04% | 12.14B | |
-0.47% | 11.99B |
- Stock Market
- Equities
- LIXT Stock